They are approved for the treatment of atopic dermatitis but not for hand eczema of other causes. Although there is only a small amount of short-term trial evidence available for tacrolimus 0·1% ...

Current treatments for chronic hand eczema (CHE) generally fall into two buckets: Either they battle inflammation but lead to ...

The US Food and Drug Administration (FDA) has approved Organon’s Vtama (tapinarof) cream, 1% to treat atopic dermatitis in ...

Adam Christman, DVM, MBA spoke with Andrew Rosenberg, DVM, DACVD about how Zenrelia is a JAK inhibitor designed to disrupt cytokine signaling pathways that trigger itch and inflammation related to ...

According to newly published research, the exposure to nature provided by the Re-Connecting Nature forest microbe extract has ...

This article discusses the two conditions, their differences, and how to tell them apart, as well as their symptoms, diagnosis, and treatment options. Atopic dermatitis (AD) is the most common ...

The global hand eczema treatment market is projected to experience robust growth, with a market value of USD 53 million in ...

Crisaborole two percent ointment is a non-steroidal anti-inflammatory medication approved for treating mild-to-moderate atopic dermatitis in patients as young as three months old in countries like the ...

The US Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for ...

Andrew Rosenberg, DVM, and Adam Christman, DVM, MBA, talk about shortcomings of treatments approved for canine allergic and atopic dermatitis and react to the availability of a novel JAK inhibitor.